Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin

por Carey, Robyn M, Blusztajn, Jan K, Slack, Barbara E
Publicado 2011

MicroRNAs as Candidate Biomarkers for Alzheimer’s Disease

por Kanach, Colin, Blusztajn, Jan K., Fischer, Andre, Delalle, Ivana
Publicado 2021

BMP9 Protects Septal Neurons from Axotomy-Evoked Loss of Cholinergic Phenotype

por Lopez-Coviella, Ignacio, Mellott, Tiffany J., Schnitzler, Aletta C., Blusztajn, Jan K.
Publicado 2011

Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice

por Mellott, Tiffany J., Huleatt, Olivia M., Shade, Bethany N., Pender, Sarah M., Liu, Yi B., Slack, Barbara E., Blusztajn, Jan K.
Publicado 2017

Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Mode...

por Mellott, Tiffany J., Huleatt, Olivia M., Shade, Bethany N., Pender, Sarah M., Liu, Yi B., Slack, Barbara E., Blusztajn, Jan K.
Publicado 2017